Profile: Transgenomic, Inc. is a global biotechnology company specializing in high sensitivity genetic variation and mutation analysis. We provide products & services in DNA mutation detection and discovery for clinical research, clinical molecular diagnostics & pharmacogenomic analyses. We offer the Wave® system and associated consumables specifically designed for use in genetic variation detection & single- & double-stranded DNA/RNA analysis & purification. The Surveyor® mutation detection kits and Surveyor Check-It Kit provide reagents and protocols for high sensitivity detection of mutations in DNA.

The company was founded in 1997, has revenues of USD 1-5 Million, has ~60 employees. OTC:TBIO (SEC Filings)